<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="6015">Isoflurane</z:chebi> preconditioning improved short-term neurological outcome after focal <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e> in adult rats </plain></SENT>
<SENT sid="1" pm="."><plain>It is not known whether <z:chebi fb="0" ids="4445">desflurane</z:chebi> induces a delayed phase of preconditioning in the brain and whether <z:chebi fb="0" ids="6015">isoflurane</z:chebi> preconditioning-induced neuroprotection is long-lasting </plain></SENT>
<SENT sid="2" pm="."><plain>Two months-old Sprague-Dawley male rats were exposed to or were not exposed to <z:chebi fb="0" ids="6015">isoflurane</z:chebi> or <z:chebi fb="0" ids="4445">desflurane</z:chebi> for 30 min and then subjected to a 90 min middle cerebral <z:mp ids='MP_0006134'>arterial occlusion</z:mp> (MCAO) at 24 h after the <z:chebi fb="164" ids="38867">anesthetic</z:chebi> exposure </plain></SENT>
<SENT sid="3" pm="."><plain>Neurological outcome was evaluated at 24 h or 4 weeks after the MCAO </plain></SENT>
<SENT sid="4" pm="."><plain>The density of the terminal deoxynucleotidyl transferase biotinylated <z:chebi fb="6" ids="15713">UTP</z:chebi> nick end labeling (TUNEL) positive cells in the penumbral cerebral cortex were assessed 4 weeks after the MCAO </plain></SENT>
<SENT sid="5" pm="."><plain>Also, rats were pretreated with <z:chebi fb="0" ids="6015">isoflurane</z:chebi> or <z:chebi fb="0" ids="4445">desflurane</z:chebi> for 30 min </plain></SENT>
<SENT sid="6" pm="."><plain>Their cerebral cortices were harvested for quantifying B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo>-2 (Bcl-2) expression 24 h later </plain></SENT>
<SENT sid="7" pm="."><plain>Here, we showed that pretreatment with 1.1% or 2.2% <z:chebi fb="0" ids="6015">isoflurane</z:chebi>, but not with 6% or 12% <z:chebi fb="0" ids="4445">desflurane</z:chebi>, increased Bcl-2 expression in the cerebral cortex, improved neurological functions and reduced <z:mpath ids='MPATH_124'>infarct</z:mpath> volumes evaluated at 24 h after the MCAO </plain></SENT>
<SENT sid="8" pm="."><plain><z:chebi fb="0" ids="6015">Isoflurane</z:chebi> preconditioning also improved neurological functions and reduced brain <z:mpath ids='MPATH_124'>infarct</z:mpath> volumes in rats evaluated 4 weeks after the MCAO </plain></SENT>
<SENT sid="9" pm="."><plain><z:chebi fb="0" ids="6015">Isoflurane</z:chebi> preconditioning also decreased the density of TUNEL-positive cells in the penumbral cerebral cortex </plain></SENT>
<SENT sid="10" pm="."><plain>We conclude that <z:chebi fb="0" ids="6015">isoflurane</z:chebi> preconditioning improves short-term and long-term neurological outcome and reduces delayed cell <z:hpo ids='HP_0011420'>death</z:hpo> after transient focal <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e> in adult rats </plain></SENT>
<SENT sid="11" pm="."><plain>Bcl-2 may be involved in the <z:chebi fb="0" ids="6015">isoflurane</z:chebi> preconditioning effect </plain></SENT>
<SENT sid="12" pm="."><plain><z:chebi fb="0" ids="4445">Desflurane</z:chebi> pretreatment did not induce a delayed phase of neuroprotection </plain></SENT>
</text></document>